Capital Square’s Sanofi SNY Stock Holding History

Capital Square’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-1,168	Closed	-$51K	–	261
2020 Q1	$51K	Buy	+1,168	New	+$55.9K	0.06%	206

Other funds holding SNY

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Capital Square's SNY Position: Q2 2020 in Review

Capital Square sold out of Sanofi (SNY) in Q2 2020, closing a stake of 1,168 shares — an estimated $51K sold.

Capital Square first reported a position in SNY in Q1 2020 and held it in 1 quarter. The position peaked at $51K in Q1 2020. 582 funds tracked by Wall St. Rank hold SNY as of Q2 2020.

Capital Square reported no remaining Sanofi position as of Q2 2020 after selling out during the quarter.
Capital Square sold 1,168 Sanofi shares in Q2 2020, an estimated $51K.
Capital Square first reported a position in Sanofi in Q1 2020 and held it in 1 quarter.
Capital Square's Sanofi position peaked at $51K in Q1 2020.
582 funds tracked by Wall St. Rank held Sanofi as of Q2 2020.

Based on Capital Square's 13F filing for Q2 2020, filed 27 Jul 2020.